Literature DB >> 7673240

A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1.

C Skerka1, E L Decker, P F Zipfel.   

Abstract

Activation of the interleukin 2 (IL-2) gene after antigen recognition is a critical event for T cell proliferation and effector function. Prior studies have identified several transcription factors that contribute to the activity of the IL-2 promoter in stimulated T lymphocytes. Here we describe a novel regulatory element within the IL-2 promoter located immediately upstream of the nuclear factor of activated T cell (NFAT) domain. This region (termed the zinc finger protein binding region (ZIP)) serves as binding site for two differently regulated zinc finger proteins: the constitutively expressed transcription factor Sp1 and the inducible early growth response protein EGR-1. In unstimulated cells which do not secrete IL-2, only Sp1 binds to this region, while in stimulated IL-2 secreting cells the inducible EGR-1 protein recognizes this element. In Jurkat T cells, the ZIP site serves as an activator for IL-2 gene expression, and a combination of ZIP and NFAT binding sites is required for maximal IL-2 promoter activity. These results suggest a critical role of the ZIP site for IL-2 promoter activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7673240     DOI: 10.1074/jbc.270.38.22500

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Pathways of Egr-1-mediated gene transcription in vascular biology.

Authors:  E S Silverman; T Collins
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

2.  Zinc finger transcription factors as molecular targets for nitric oxide-mediated immunosuppression: inhibition of IL-2 gene expression in murine lymphocytes.

Authors:  D Berendji; V Kolb-Bachofen; P F Zipfel; C Skerka; C Carlberg; K D Kröncke
Journal:  Mol Med       Date:  1999-11       Impact factor: 6.354

Review 3.  Egr-1 is a major vascular pathogenic transcription factor in atherosclerosis and restenosis.

Authors:  Florian Blaschke; Dennis Bruemmer; Ronald E Law
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

4.  GGPPS, a new EGR-1 target gene, reactivates ERK 1/2 signaling through increasing Ras prenylation.

Authors:  Ning Shen; Yue Shao; Shan-Shan Lai; Long Qiao; Run-Lin Yang; Bin Xue; Fei-Yan Pan; Hua-Qun Chen; Chao-Jun Li
Journal:  Am J Pathol       Date:  2011-10-06       Impact factor: 4.307

5.  Early growth response-1 is required for CD154 transcription.

Authors:  Randy Q Cron; Rupa Bandyopadhyay; Anna Genin; Michael Brunner; Gilbert J Kersh; Jiyi Yin; Terri H Finkel; Mary K Crow
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

Review 6.  Early growth response 1 (EGR1) activation in initial stages of host-pathogen interactions.

Authors:  Rajashri Banerji; Sunil D Saroj
Journal:  Mol Biol Rep       Date:  2021-03-30       Impact factor: 2.316

7.  Oxidative stress suppresses transcription factor activities in stimulated lymphocytes.

Authors:  E Flescher; H Tripoli; K Salnikow; F J Burns
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

8.  Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1.

Authors:  S Srivastava; M N Weitzmann; R B Kimble; M Rizzo; M Zahner; J Milbrandt; F P Ross; R Pacifici
Journal:  J Clin Invest       Date:  1998-11-15       Impact factor: 14.808

9.  Cigarette smoke-induced pulmonary inflammatory responses are mediated by EGR-1/GGPPS/MAPK signaling.

Authors:  Ning Shen; Tao Gong; Jian-Dong Wang; Fan-Li Meng; Long Qiao; Run-Lin Yang; Bin Xue; Fei-Yan Pan; Xiao-Jun Zhou; Hua-Qun Chen; Wen Ning; Chao-Jun Li
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

10.  Nuclear receptors modulate the interaction of Sp1 and GC-rich DNA via ternary complex formation.

Authors:  M Husmann; Y Dragneva; E Romahn; P Jehnichen
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.